The therapeutic potential of cannabinoids to manage several clinical conditions, including pain, inflammation, sleep disorders, and epilepsy, is finding support through a growing body of evidence.
The use of dietary supplements to manage pain is common in individuals with musculoskeletal disorders.
Group acupuncture may alleviate pain and improve quality of life in patients with painful diabetic neuropathy.
Approximately half of the 14% of Americans who have severe headache and migraine report having tried interventions such as meditation, yoga, and deep breathing exercises.
For patients with chronic pain (CP), both mindfulness-based stress reduction (MBSR) and cognitive behavioral therapy (CBT) improve physical functioning, pain intensity, and depression.
Although cannabinoids were found to improve the pain experience in individuals subjected to experimental pain, they were not found to have analgesic effects on existing experimental pain, suggesting that these agents may modulate affective processes.
In a randomized study, researchers sought to determine the effect of IV injections of coix seed oil, a Chinese CAM, on pain and quality of life measures for patients with advanced cancer.
Dispositional mindfulness may help reduce the risk for opioid misuse in patients with chronic pain by attenuating opioid craving and directing attention to naturally rewarding stimuli.
Improving the ability to communicate about pain may help reduce the negative effects associated with ambivalence over emotional expression on pain catastrophizing in patients with osteoarthritis pain.
Peripheral nerve field stimulation with electroacupuncture may represent a less invasive mode of treating primary headache.
